Delivery Order SPE2DB24D1205-SPE2DB25FCZGV
- Not listed
- The Defense Logistics Agency awarded a $10,100.87 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Humulin R 500 unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a $4,992.08 delivery order to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 17, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics...
- The Defense Logistics Agency awarded a $3,252.20 delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens on July 31, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price, competitively awarded contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $25,734.37 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with completion scheduled for September 4, 2025. This contract utilizes a firm fixed price structure and carries no set-aside designation, indicating it was awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens, valued at $3,050.78 under firm fixed pricing. This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $12,000.90. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $7,657.16. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a ceiling value of $10,014.11 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of June 2, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $21,731.92 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed-price pricing with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location. This delivery order represents a competitive procurement action under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,646.28 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for completion by September 8, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZGVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, with a ceiling value of $14,738.91. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with performance completion targeted for August 7, 2025, and will be fulfilled at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare systems globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical supply contracts with the Defense Logistics Agency covering a broad spectrum of pharmaceutical products and medical supplies. The company's federal contracting activity demonstrates consistent capability in delivering both brand-name and generic medications, specialty treatments, and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for insulin reflects the company's ongoing role as a critical vendor in the federal medical procurement supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.7k | 8/6/25 |